EIP
SUPN icon

Epoch Investment Partners’s Supernus Pharmaceuticals SUPN Stock Holding History

Epoch Investment Partners’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,610
Closed -$524K – 290
2025
Q2 		$524K Sell
16,610
-27,574
-62% -$884K ﹤0.01% 265
2025
Q1 		$1.45M Sell
44,184
-41,507
-48% -$1.47M 0.01% 234
2024
Q4 		$3.1M Buy
85,691
+31,957
+59% +$1.13M 0.02% 218
2024
Q3 		$1.68M Buy
53,734
+17,878
+50% +$558K 0.01% 270
2024
Q2 		$959K Sell
35,856
-166,411
-82% -$4.82M ﹤0.01% 312
2024
Q1 		$6.9M Sell
202,267
-144,069
-42% -$4.29M 0.03% 264
2023
Q4 		$10M Sell
346,336
-41,317
-11% -$1.1M 0.05% 262
2023
Q3 		$10.7M Sell
387,653
-88,386
-19% -$2.69M 0.07% 252
2023
Q2 		$14.3M Buy
476,039
+1,216
+0.3% +$42.5K 0.08% 223
2023
Q1 		$17.2M Buy
474,823
+520
+0.1% +$20K 0.1% 208
2022
Q4 		$16.9M Sell
474,303
-16,937
-3% -$589K 0.1% 215
2022
Q3 		$16.6M Buy
491,240
+15,199
+3% +$495K 0.11% 207
2022
Q2 		$13.8M Sell
476,041
-19,074
-4% -$546K 0.08% 234
2022
Q1 		$16M Buy
495,115
+36,960
+8% +$1.13M 0.08% 234
2021
Q4 		$13.4M Buy
458,155
+68,750
+18% +$2.09M 0.07% 248
2021
Q3 		$10.4M Buy
+389,405
New +$10.5M 0.06% 261

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Epoch Investment Partners's SUPN Position: Q3 2025 in Review

Epoch Investment Partners sold out of Supernus Pharmaceuticals (SUPN) in Q3 2025, closing a stake of 16,610 shares — an estimated $524K sold.

Epoch Investment Partners first reported a position in SUPN in Q3 2021 and held it in 16 quarters. The position peaked at $17.2M in Q1 2023. 310 funds tracked by Wall St. Rank hold SUPN as of Q3 2025.

  • Epoch Investment Partners reported no remaining Supernus Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Epoch Investment Partners sold 16,610 Supernus Pharmaceuticals shares in Q3 2025, an estimated $524K.
  • Epoch Investment Partners first reported a position in Supernus Pharmaceuticals in Q3 2021 and held it in 16 quarters.
  • Epoch Investment Partners's Supernus Pharmaceuticals position peaked at $17.2M in Q1 2023.
  • 310 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2025.

Based on Epoch Investment Partners's 13F filing for Q3 2025, filed 13 Nov 2025.